关于：使用帕利珠单抗预防先天性心脏病婴儿呼吸道合胞病毒感染的建议。 - Suppr

Re: recommendation for the use of palivizumab as prophylaxis against respiratory syncytial virus in infants with congenital cardiac disease.

作者信息

Onuzo Obed C

出版信息

Cardiol Young. 2004 Aug;14(4):466-7; author reply 467-9. doi: 10.1017/S1047951104244225.

DOI:10.1017/S1047951104244225

PMID:15680062

Abstract

摘要

相似文献

Re: recommendation for the use of palivizumab as prophylaxis against respiratory syncytial virus in infants with congenital cardiac disease.

Cardiol Young. 2004 Aug;14(4):466-7; author reply 467-9. doi: 10.1017/S1047951104244225.

Nationwide survey of palivizumab for respiratory syncytial virus prevention in Japanese children with congenital heart disease.

Pediatr Infect Dis J. 2008 Dec;27(12):1108-9. doi: 10.1097/INF.0b013e3181801d76.

Cost-effectiveness of respiratory syncytial virus prophylaxis in various indications.

Arch Pediatr Adolesc Med. 2011 Jun;165(6):498-505. doi: 10.1001/archpediatrics.2010.298. Epub 2011 Feb 7.

Palivizumab prophylaxis, respiratory syncytial virus, and subsequent recurrent wheezing.

J Pediatr. 2007 Jul;151(1):34-42, 42.e1. doi: 10.1016/j.jpeds.2007.02.032.

Optimizing the delivery and use of a new monoclonal antibody in children with congenital heart disease: a successful provincial respiratory syncytial virus prophylaxis program.

Can J Cardiol. 2007 May 1;23(6):463-6. doi: 10.1016/s0828-282x(07)70785-7.

Risk of severe respiratory syncytial virus disease, identification of high risk infants and recommendations for prophylaxis with palivizumab.

Pediatr Infect Dis J. 2004 Mar;23(3):284-5. doi: 10.1097/01.inf.0000121203.33560.f9.

Impact of palivizumab prophylaxis on respiratory syncytial virus hospitalizations in high risk Alaska Native infants.

Pediatr Infect Dis J. 2003 Jun;22(6):540-5. doi: 10.1097/01.inf.0000069768.34383.18.

The use of humanized monoclonal antibodies for the prevention of respiratory syncytial virus infection.

Clin Dev Immunol. 2013;2013:359683. doi: 10.1155/2013/359683. Epub 2013 Jun 11.

Effect of palivizumab prophylaxis on subsequent recurrent wheezing in preterm infants.

Pediatrics. 2013 Nov;132(5):811-8. doi: 10.1542/peds.2013-0982. Epub 2013 Oct 14.

Cost effectiveness of palivizumab in children with congenital heart disease in Germany.

J Med Econ. 2009;12(4):301-8. doi: 10.3111/13696990903347172.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Re: recommendation for the use of palivizumab as prophylaxis against respiratory syncytial virus in infants with congenital cardiac disease.

作者信息

出版信息

相似文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

Re: recommendation for the use of palivizumab as prophylaxis against respiratory syncytial virus in infants with congenital cardiac disease.

作者信息

出版信息

相似文献